<DOC>
	<DOC>NCT02620124</DOC>
	<brief_summary>Back ground: A single dose of GnRH analogue in the luteal phase is reported to improve the outcome of IVF/ICSI treatments but the effect in FET cycles has not been reported. Aim: To compare the results of frozen thawed embryo transfers with and without GnRHa analogue support Primary end point: IR, PR, on going PR Secondary end point: hCH, E2 and progesterone levels 14 days after thawing</brief_summary>
	<brief_title>GnRH Agonist as Luteal Support in FET Cycles</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Triptorelin Pamoate</mesh_term>
	<criteria>20 45 year old women comig to frozen thawed embryo transfer The age of the woman over 42 years during the initial ICF/ICSI treatment from which the embryos derive Abnormal uterus Known abnormality of karyotype of the woman or her partner Severe male factor as an exclusive reason for subfertility Allegy for triptorelin acetate</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>